Last reviewed · How we verify

The Effect of FOsamprenavir/Ritonavir on the Pharmacokinetics of a Single-dose of the Antipsychotic Agent olanZApine (FORZA)

NCT00977301 Phase 1 COMPLETED

The effect of fosamprenavir/ritonavir (steady state) on the pharmacokinetics of a single dose of olanzapine will be studied. In this study, the investigators expect an inducible effect of fosamprenavir/ritonavir on the CYP1A2 and UGT metabolism of olanzapine.

Details

Lead sponsorRadboud University Medical Center
PhasePhase 1
StatusCOMPLETED
Enrolment24
Start date2009-11
Completion2010-08

Conditions

Interventions

Primary outcomes

Countries

Netherlands